Authors
Loading...
Commentary discusses barriers to sustainable innovation in diabetes devices, highlighting regulatory impacts on design efforts.
Hossmann et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: